adrenals Flashcards

corticosteroids: explain the main clinical uses of exogenous corticosteroids including mode of action; recall how exogenous corticosteroids differ

1
Q

two types of corticosteroid receptor

A

glucocorticoid (GR) and mineralocorticoid (MR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

GR vs MR: distribution

A

GR widely distributed, MR discretely distributed (kidney)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

GR vs MR: selectivity

A

GR selective for glucocorticoids, MR unselective between aldosterone and cortisol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

GR vs MR: affinity for cortisol

A

GR low affinity, MR high affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how are MRs protected from cortisol (preventing cortisol binding to it all the time); significance in Cushing’s

A

11B-hydroxysteroid dehydrogenase 2 (11BHSD) inactivates cortisol to cortisone before it binds, and cortisone cannot bind to MR; in Cushing’s, hypokalaemia as excess cortisol overwhelms 11BHSD, so this binds to MR, promoting Na+ reabsorption and K+ excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

4 drugs with receptor selectivity for GR and/or MR

A

hydrocortisone, prednisolone, dexamethasone, fludrocortisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

GR and MR selectivity of hydrocortisone

A

glucocorticoid with mineralocorticoid activity at high dose (mimics cortisol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

GR and MR selectivity of prednisolone

A

glucocorticoid with weak mineralocorticoid activity; used as immunosuppressant for inflammatory diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

GR and MR selectivity of dexamethasone; what does it help diagnose

A

synthetic glucocorticoid with no mineralocorticoid activity (used to diagnose Cushing’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GR and MR selectivity of fludrocortisone

A

mineralocorticoid with no glucocorticoid activity; aldosterone analogue (used as aldosterone substitute)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

drug structures and varying affinities explained

A

have varying affinities to receptors by having subtle structural differences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

pharmacokinetics: 2 routes of administration of exogenous corticosteroids

A

oral, parenteral (IV or IM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pharmacokinetics: exogenous corticosteroids which are orally administered

A

all: hydrocortisone, prednisolone, dexamethasone, fludrocortisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pharmacokinetics: exogenous corticosteroids which are parenteral administered (IV or IM); why isn’t fludrocortisone given IV

A

hydrocortisone, dexamethasone; as hydrocortisone has mineralocorticoid effects at high doses, fludrocortisone doesn’t have to be given IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

pharmacokinetics: distribution of exogenous corticosteroids

A

bind to plasma proteins (cortisol binding globulin and albumin) as circulating cortisol does

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

pharmacokinetics: duration of hydrocortisone action

A

8 hours - quickly metabolised so several times a day

17
Q

pharmacokinetics: duration of prednisolone action

A

12 hours - once a day

18
Q

pharmacokinetics: duration of dexamethasone action

A

40 hours - potent so used in dexamethasone test for Cushing’s

19
Q

what is primary adrenocortical failure, and effect on production and release of steroid hormones

A

Addison’s disease, so no aldosterone, cortisol or sex steroids (sex steroids don’t need to be replaced as most produced by gonads)

20
Q

how is Addison’s disease treated (not Addisonian crisis)

A

hydrocortisone (cortisol replacement) and fludrocortisone (aldosterone replacement) by mouth

21
Q

what is secondary adrenocortical failure, and effect on production and release of steroid hormones

A

ACTH deficiency, so patient lacks cortisol but normal aldosterone (RAAS pathway as adrenal cortex fine)

22
Q

how is ACTH deficiency treated

A

hydrocortisone or prednisolone to replace cortisol

23
Q

what is an acute adrenocortical failure also known as

A

Addisonian crisis (more severe form of Addisons so severe hypotension)

24
Q

treatment of Addisonian crisis (3 things)

A

IV 0.9% NaCl to rehydrate (increase blood pressure, replace Na+ without K+), immediate high dose hydrocortisone (IV infusion or IM every 6 hours to produce mineralocorticoid effect by overwhelming 11BHSD; therefore fludrocortisone doesn’t need to be administered straight away), 5% dextrose if hypogylcaemic

25
Q

what is congenital adrenal hyperplasia

A

congenital lack of enzymes needed for adrenal steroid synthesis (95% cases lack 21-hydroxylase)

26
Q

effect of having a) partial and b) complete 21-hydroxylase deficiency on steroid production

A

a) aldosterone and cortisol deficient, excess sex steroids; b) aldosterone and cortisol absent, excess sex steroids

27
Q

what is measured to make congenital adrenal hyperplasia diagnosis if 21-hydroxylase deficiency

A

17a-hydroxyprogesterone; accumulates as ACTH drive but immediately before enzyme ‘block’, so high levels

28
Q

3 objectives of congenital adrenal hyperplasia therapy

A

replace cortisol, suppress ACTH (therefore suppressing adrenal androgen production), replace aldosterone in salt wasting forms

29
Q

treatment of congenital adrenal hyperplasia to stop ACTH drive

A

cortisol: dexamethasone 1/day, pm or hydrocortisone 2-3/day, high dose pm (try to reduce ACTH and adrenal androgen production); aldosterone: fludrocortisone

30
Q

what is measured to monitor and optimise therapy for congenital adrenal hyperplasia (if bigger dose of glucocorticoid to stop ACTH drive, can develop Cushing’s)

A

17a-hydroxyprogesterone; clinical assessment: Cushingoid - GC dose too high; hirsutism - GC dose too low, causing ACTH (and therefore testosterone production) to rise

31
Q

additional measure in subjects with adrenocortical failure and vulnerable to stress (e.g. unwell) and why

A

increase glucocorticoid dosage, as if in stress e.g. unwell with pneumonia or UTI, 10x more cortisol produced than normal

32
Q

what 2 occasions is glucocorticoid dosage increased during stress when using corticosteriod replacement therapy for adrenocortical failure

A

in minor illness (2x normal dose to mimic what body would normally be doing), surgery (general anaesthetic is stress to body)

33
Q

how is glucocorticoid dosage increased before surgery

A

hydrocortisone (IM), with pre-med and at 6-8 hour intervals; oral once eating and drinking

34
Q

what should patients with adrenocortical failure carry and wear to ensure effective treatment if unwell

A

steroid alert card, MedicAlert bracelet/necklace to ensure adequate treatment as in time of stress